← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2026-02-26

Drug application

FDA Application #

ANDA220103

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

DAPSONE

Active ingredients

DAPSONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ZYDUS LIFESCIENCES

Manufacturer

Viona Pharmaceuticals Inc

First approval

2026-02-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown